Literature DB >> 19787364

Cytokine-related genes and oxidation-related genes detected in preeclamptic placentas.

Gui Se Ra Lee1, Yoon Seong Joe, Sa Jin Kim, Jong Chul Shin.   

Abstract

PURPOSE: To investigate cytokine- and oxidation-related genes for preeclampsia using DNA microarray analysis.
METHODS: Placentas were collected from 13 normal pregnancies and 13 patients with preeclampsia. Gene expression was studied using DNA microarray. Among significantly expressed genes, we focused on genes associated with cytokines and oxidation, and the results were confirmed using quantitative real time-polymerase chain reaction (QRT-PCR).
RESULTS: 415 genes out of 30,940 genes were altered by > or =2-fold in the microarray analysis. 121 up-regulated genes and 294 down-regulated genes were found to be in preeclamptic placenta. Six cytokine-related genes and 5 oxidation-related genes were found from among the 121 up-regulated genes. The cytokine-related genes studied included oncostatin M (OSM), fms-related tyrosine kinase (FLT1) and vascular endothelial growth factor A (VEGFA), and the oxidation-related genes studied included spermine oxidase (SMOX), l cytochrome P450, family 26, subfamily A, polypeptide 1 (CYP26A1), acetate dehydrogenase A (LDHA). These six genes were also significantly higher in placentas from patients with preeclampsia than in those from women with normal pregnancies. The placental tissue of patients with preeclampsia showed significantly higher mRNA expression of these six genes than the normal group, using QRT-PCR.
CONCLUSION: DNA microarray analysis is one of the great methods for simultaneously detecting the functionally associated genes of preeclampsia. The cytokine-related genes such as OSM, FLT1 and VEGFA, and the oxidation-related genes such as LDHA, CYP26A1 and SMOX might prove to be the starting point in the elucidation of the pathogenesis of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787364     DOI: 10.1007/s00404-009-1222-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  15 in total

1.  VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.

Authors:  Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

2.  Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays.

Authors:  Tao Meng; Haiying Chen; Manni Sun; He Wang; Ge Zhao; Xiaoshuang Wang
Journal:  OMICS       Date:  2012-06

3.  The placenta in preeclampsia.

Authors:  James M Roberts; C Escudero
Journal:  Pregnancy Hypertens       Date:  2012-04-01       Impact factor: 2.899

4.  Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia.

Authors:  Deepali P Sundrani; Umakar S Reddy; Asmita A Joshi; Savita S Mehendale; Preeti M Chavan-Gautam; Anandwardhan A Hardikar; Giriraj R Chandak; Sadhana R Joshi
Journal:  Clin Epigenetics       Date:  2013-04-26       Impact factor: 6.551

5.  Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report.

Authors:  Brenda Dawley
Journal:  Obstet Gynecol Int       Date:  2011-05-15

Review 6.  Gestational tissue transcriptomics in term and preterm human pregnancies: a systematic review and meta-analysis.

Authors:  Haley R Eidem; William E Ackerman; Kriston L McGary; Patrick Abbot; Antonis Rokas
Journal:  BMC Med Genomics       Date:  2015-06-05       Impact factor: 3.063

7.  Meta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to Preeclampsia.

Authors:  Miranda van Uitert; Perry D Moerland; Daniel A Enquobahrie; Hannele Laivuori; Joris A M van der Post; Carrie Ris-Stalpers; Gijs B Afink
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 8.  A lesson for cancer research: placental microarray gene analysis in preeclampsia.

Authors:  Frank Louwen; Cornelia Muschol-Steinmetz; Joscha Reinhard; Anke Reitter; Juping Yuan
Journal:  Oncotarget       Date:  2012-08

Review 9.  The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia.

Authors:  Pooneh Nikuei; Kianoosh Malekzadeh; Minoo Rajaei; Azim Nejatizadeh; Nasrin Ghasemi
Journal:  Iran J Reprod Med       Date:  2015-05

Review 10.  Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis.

Authors:  C Emily Kleinrouweler; Miranda van Uitert; Perry D Moerland; Carrie Ris-Stalpers; Joris A M van der Post; Gijs B Afink
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.